Evvy

Series B · New York

Vaginal microbiome testing and care

The largest vaginal microbiome dataset in the world belongs to Evvy, assembled from the results of more than 100,000 patients. Those patients, along with thousands of providers across the US, use its validated test and an AI-driven care platform that sets a personalised treatment path for each person. Analysis of the data has uncovered new biological markers behind conditions affecting women that together cost the healthcare system over $180 billion a year, and the research targets include infertility, preterm birth and gynecological cancers. Peer-reviewed journals have published the work, and it has been presented at ACOG, ASRM and IDSOG. The team works mostly in person in New York, in the office four days a week.

Last round

$40MSeries BSep 2026led by Catalio Capital Management

6open rolesProduct, GTM, Sales, Marketing, BizOps, Data, and Chief of Staff

RoleEst. Compensation

VP of MarketingEvvyMarketing · Director-VP+ · Series B · On-site · New York

—